It varies: There are average numbers of survival os metastatic prostate cancer treated with hormonal therapy. They range a little over 3 years. The difficult problem is that some people have a short improvement and some live decades with metastatic disease. The best help to guess an outcome, is the length of time the cancer stays under control with the first treatment.
Answered 7/27/2012
5.7k views
Longer than ever: Newer therapies are constantly emerging for this problem, including radium for bony metastases, shown to significantly improve survival. Other drugs such as abiraterone and mdv3100 show much promise as well. The outlook has never been better for men in this unfortunate situation.
Answered 11/2/2017
5.7k views
6 doctors weighed in across 4 answers
A doctor has provided 1 answer
6 doctors weighed in across 2 answers
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question